M37-15729-29140
2 vaccinations
2 coded responses
10 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 190 / PA
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
- 2020-12-28
- 2020-12-29
- 2020-12-30
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: Good · Muscle or body achesFree text: May be secondary to working outMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-17
- 2021-01-26
- 2021-02-03
- 2021-02-11
- 2021-02-16
-
2021-02-23
Survey response — day 42, dose 2MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Poor · Be unable to workFree text: Came down with a little cold started on Saturday 2/20. COVID negativeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): May be secondary to working out
Release 4 — day 42, dose 2
Symptoms: Came down with a little cold started on Saturday 2/20. COVID negative
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release